Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. is an oncology-focused biotechnology company developing targeted therapies for various types of cancer, including acute myeloid leukemia, lymphoma, and solid tumors.
/10
Transparency ranking
Work at Bio-Path Holdings, Inc.?
Tell us what we're missing about working at Bio-Path Holdings, Inc. so we can make the job search more transparent for everyone.
Tell us what it's like to work at Bio-Path Holdings, Inc.!Description
Bio-Path Holdings, Inc. is an oncology-focused biotechnology company dedicated to developing targeted cancer treatments that offer effective therapy without harsh side effects. The company leverages its innovative DNAbilize® platform technology to deliver DNA therapeutics directly to cancer cells. Bio-Path is headquartered in Houston, Texas and has a strong intellectual property position for DNAbilize®, including composition of matter and methods patents.
Bio-Path's lead product candidate, prexigebersen (Liposomal Grb2 Antisense), is being assessed in a Phase 2 trial in combination with front-line therapy for acute myeloid leukemia (AML). The company is also developing BP1001-A, a modified product of prexigebersen, for the treatment of solid tumors and BP1002 (Liposomal Bcl-2 Antisense) is being evaluated in Phase 1 trials in lymphoma and AML. Bio-Path seeks to apply DNAbilize® to new protein targets in cancer and other disease indications.
Mission
Bio-Path Holdings, Inc. is a biotechnology company focused on developing targeted therapies for various cancers, particularly acute myeloid leukemia (AML), lymphoma, and solid tumors. Their mission is to provide effective cancer treatments that are less toxic than conventional chemotherapy, offering a gentler approach to treating these challenging diseases. The company's core technology, DNAbilize®, utilizes liposomal delivery to safely and efficiently transport antisense DNA therapeutics directly to cancer cells, offering a potentially revolutionary approach to cancer treatment.
Culture
Bio-Path Holdings promotes a culture focused on innovation and collaboration, driven by a strong commitment to developing life-saving therapeutics for cancer patients. The company emphasizes a patient-centric approach, seeking to provide gentler treatment options for those facing challenging cancers. This dedication to making a difference is reflected in the company's strong relationships with academic and clinical leaders, fostering an environment where cutting-edge research and development go hand in hand with a deep sense of purpose.
Similar companies. But verified.
